Industry Monthly
May 2026 Industry Monthly
A monthly digest of policy, market, and technology developments across the pharmaceutical industry, based on public sources.
Policy & Pricing
MHLW opens applications for a drug stable-supply subsidy
The MHLW opened applications (through May 29) for a subsidy supporting pharmaceutical wholesalers. Eligibility covers stable-supply optimization, regional contribution, and disaster BCP, and includes promotion of single-item price negotiation.
Source: MHLWExpert's View
Stable supply directly determines whether patients can receive their medicines without interruption. Direct support to wholesalers is unusual; the real question is how far it reduces shortages at the pharmacy counter.
Chuikyo reviews new-drug pricing listings (650th General Assembly)
Topics included new-drug NHI price listings, reimbursement for regenerative-medicine products, optimal-use guidelines, and DPC handling of high-cost drugs. A list of drugs slated for May 20 listing was presented.
Source: MHLWExpert's View
New-drug listings shape how quickly patients can reach innovative therapies. The essential question is how to balance patient access with the sustainability of the insurance system.
Market & Business
Japan's drug market grows 3.1% to ¥11.8 trillion
A record high for the fourth straight year. The GLP-1 drug Mounjaro grew 3.2x to surpass ¥100 billion.
Source: AnswersNewsExpert's View
The GLP-1 surge reflects strong demand, but for patients, appropriate use and equitable access matter most. Market growth does not automatically translate into benefit for individual patients.
Top 7 Japanese drugmakers post 41% rise in operating profit
For the year ended March 2026, revenue rose 5.4% and operating profit 41.0%, driven by global-product growth and smaller impairments; five companies hit record revenue.
Source: AnswersNewsExpert's View
Strong earnings can fund the next generation of therapies. Patients benefit when those profits flow back into R&D and improved access — what matters is how the results are used.
Drugstores expand reach via supermarket co-locations
Under a strategy of drawing footfall with food and securing margin with pharmaceuticals, co-located stores with supermarkets are expanding.
Source: NikkeiExpert's View
Easier access to OTC and health products during everyday shopping supports self-care. At the same time, opportunities for pharmacist consultation remain essential for safe use.
Pharmacies squeezed by dual fee revisions
Industry voices note that the overlap of drug-price and dispensing-fee revisions is intensifying pressure on pharmacy operations.
Source: PHARMACY NEWSBREAKExpert's View
Pharmacies are the most accessible point of care for patients. If local pharmacies become unviable, the elderly and those in rural areas in particular may find it harder to obtain their medicines.
* This report is edited by Yap Inc. based on publicly available sources. “Expert’s View” reflects the perspective of CEO Masaya Yamamoto (a NewsPicks Expert). Please refer to the original source for details on each item.
View More News